Market Overview

UPDATE: Piper Jaffray Reiterates Neutral Rating, Lowers PT on Almost Family

Related AFAM
Home Health Care Stocks In Play Following Gentiva/Kindred Deal
Top 4 Small-Cap Stocks In The Home Health Care Industry With The Highest Profit Margin

In a report published Wednesday, Piper Jaffray & Co. reiterated its Neutral rating on Almost Family (NASDAQ: AFAM), but slightly lowered its price target from $23.00 to $22.00.

Piper Jaffray noted, “AFAM reported in-line EPS on slightly lower revenues. On Nov. 2nd, the company was informed by the SEC that it had concluded its investigation and will not recommend enforcement action, which we view positively as the decision removes an overhang. Visiting Nurse (VN) admissions continue to be weak as total admissions increased 1.6% y/y, while Medicare admissions decreased 2.5% y/y and Medicare recertifications decreased 2.3% y/y. While we are encouraged about the conclusion of the SEC investigation, potential reimbursement headwinds and the uncertainty of rebasing in 2014 keep us on the sidelines. Maintain Neutral rating and tweaking our PT to $22 from $23, based on 12x our revised FY13 EPS estimate of $1.84.”

Almost Family closed on Tuesday at $21.06.

Latest Ratings for AFAM

DateFirmActionFromTo
Aug 2014JefferiesUpgradesHoldBuy
Dec 2013RBC CapitalUpgradesUnderperformSector Perform
Nov 2013Avondale PartnersUpgradesMarket PerformMarket Outperform

View More Analyst Ratings for AFAM
View the Latest Analyst Ratings

Posted-In: Piper Jaffray & Co.Analyst Color Price Target Analyst Ratings

 

Related Articles (AFAM)

Around the Web, We're Loving...

Get Benzinga's Newsletters